Equities research analysts at Goldman Sachs assumed coverage on shares of MannKind (NASDAQ:MNKD) in a research note issued to investors on Monday, TheFlyOnTheWall.com reports. The firm set a “neutral” rating and a $6.00 price target on the stock. MannKind Corp. (NASDAQ:MNKD) belongs to Healthcare sector. Its weekly performance is 8.70%. On last trading day company shares ended up $6.18. MannKind Corp. (NASDAQ:MNKD) distance from 50-day … Continue reading Trader’s Recap : MannKind Corp. (NASDAQ:MNKD), AbbVie Inc. (NYSE:ABBV), Cinemark Holdings Inc. (NYSE:CNK), LDR Holding Corporation (NASDAQ:LDRH), Stillwater Mining Co. (NYSE:SWC)